IMMUNOTHERAPY OF RECURRENT B-CELL MALIGNANCIES IN ADULT AND PAEDIATRIC PATIENTS WITH FBTA05, A TRIFUNCTIONAL ANTIBODY (ANTI-CD3 X ANTI-CD20) AND ALLOGENEIC DONOR LYMPHOCYTE INFUSION

被引：0

作者：

Buhmann, R. ^{[1
]}

Stanglmaier, M. ^{[2
]}

Schuster, F. ^{[3
]}

Simoes, B. ^{[1
]}

Menzel, H. ^{[4
]}

Ruf, P. ^{[2
]}

Peschel, C. ^{[4
]}

Lindhofer, H. ^{[2
]}

Borkhardt, A. ^{[3
]}

Kolb, H. J. ^{[1
]}

机构：

[1] Helmholtz Ctr Munich, Munich, Germany

[2] Trion Res GmbH, Munich, Germany

[3] Dept Paediat Oncol Haematol & Immunol, Dusseldorf, Germany

[4] Tech Univ Munich, Klinikum Rechts Isar, Med Clin 3, Munich, Germany

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0450

引用

页码：183 / 183

页数：1

共 50 条

[1] Immunotherapy with FBTA05 (Bi20), a trifunctional anti-CD3 x anti-CD20 antibody in recurrent childhood B-cell malignancies
Schuster, F.
Stanglmaier, M.
Woessmann, W.
Winkler, B.
Meisel, R.
Schlegel, P. G.
Lindhofer, H.
Reiter, A.
Borkhardt, A.
Buhmann, R.
[J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S247 - S247
[2] Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion
Buhmann, R.
Simoes, B.
Stanglmaier, M.
Yang, T.
Faltin, M.
Bund, D.
Lindhofer, H.
Kolb, H-J
[J]. BONE MARROW TRANSPLANTATION, 2009, 43 (05) : 383 - 397
[3] Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 × anti-CD20 antibody and donor lymphocyte infusion
R Buhmann
B Simoes
M Stanglmaier
T Yang
M Faltin
D Bund
H Lindhofer
H-J Kolb
[J]. Bone Marrow Transplantation, 2009, 43 : 383 - 397
[4] Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies
Schuster, Friedhelm R.
Stanglmaier, Michael
Woessmann, Wilhelm
Winkler, Beate
Siepermann, Meinolf
Meisel, Roland
Schlegel, Paul G.
Hess, Juergen
Lindhofer, Horst
Borkhardt, Arndt
Buhmann, Raymund
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 90 - 102
[5] Dissection of GvHD and GvL by FBTA05, a novel trifunctional anti-CD3 x anti-CD20 antibody
Buhmann, R.
Stanglmaier, M.
Simoes, B.
Menzel, H.
Peschel, C.
Ruf, P.
Lindhofer, H.
Kolb, H. -J.
[J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S123 - S123
[6] Clinical follow-up of paediatric high-risk patients with recurrent CD20 positive B-cell malignancies treated with the trifunctional antibody FBTA05 (anti-CD3 x anti-CD20)
Schuster, F.
Stanglmaier, M.
Woessman, W.
Winkler, B.
Ruf, P.
Schlegel, P.
Meisel, R.
Lindhofer, H.
Borkhardt, A.
Buhmann, R.
[J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S456 - S456
[7] Adoptive immunotherapy of recurrent B-cell malignancies after allogeneic stem cell transplantation with Bi20 (FBTA05) a CD3xCD20 trifunctional antibody and donor lymphocyte transfusion
Buhmann, R.
Simoes, B.
Stanglmaier, M.
Yang, T.
Faltin, M.
Bund, D.
Lindhofer, H.
Kolb, H. -J.
[J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S45 - S45
[8] Bi20 (FBTA05), a novel trifunctional bispecific antibody (anti-CD20 x anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels
Stanglmaier, Michael
Faltin, Margot
Ruf, Peter
Bodenhausen, Annette
Schroeder, Petra
Lindhofer, Horst
[J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1181 - 1189
[9] Adoptive immunotherapy of p53-mutated B-CLL with a trifunctional antibody (anti-CD3 x anti-CD20) and allogeneic donor lymphocyte transfusion
Buhmann, R
Stanglmaier, M
Simoes, B
Yang, T
Ruf, P
Lindhofer, H
Kolb, HJ
[J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S226 - S227
[10] Adoptive immunotherapy of p53-mutated B-CLL with a trifunctional antibody (anti-CD3 x anti-CD20) and allogeneic donor lymphocyte transfusion
Buhmann, R
Stanglmaier, M
Simoes, B
Yang, T
Ruf, P
Lindhofer, H
Kolb, HJ
[J]. BLOOD, 2005, 106 (11) : 286B - 286B

← 1 2 3 4 5 →